RBM-007
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for RBM-007, covering 2021-01-05 to 2023-06-08. Get the full timeline:
Most recent: Clinical Trial Update: A Phase II Study of RBM-007 Alone and RBM-007 With Eylea® in Subjects With Wet Age-related Macular Degeneration [Phase 2]